<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: treatment recommendations</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Gauging brain cancer survival time may get easier, study says</title>
   	 <description>(HealthDay)—Life expectancy of people with aggressive brain cancer may be easier to determine with a new method under development at the University of Alabama at Birmingham, researchers say.</description>
     <link>http://medicalxpress.com/news/2013-04-gauging-brain-cancer-survival-easier.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 10 Apr 2013 19:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284834780</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/gaugingbrain.jpg" width="90" height="90" />
</item>
<item>
     <title>Benefit of PET or PET/CT in bone and soft tissue tumors is not proven</title>
   	 <description>For patients with bone and soft tissue tumours, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in combination with computed tomography (CT). This is because no studies have directly compared the benefit of these imaging techniques with conventional diagnostics. And the few available studies on diagnostic accuracy do not show any relevant differences. This is the conclusion of the final report of the German Institute for Quality and Efficiency in Health Care (IQWiG) published on 15th February 2013.</description>
     <link>http://medicalxpress.com/news/2013-03-benefit-pet-petct-bone-soft.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 07 Mar 2013 11:45:21 EST</pubDate>
	 <guid isPermaLink="false">news281879108</guid>
	 
</item>
<item>
     <title>Digital diagnostic tools lead to patient dissatisfaction, says MU expert</title>
   	 <description>Health care practitioners now can access patients' data using electronic medical records, which often include information systems that assess individuals' medical histories and clinical research to facilitate doctors' diagnoses. A University of Missouri researcher says the increased use of computerized clinical decision support systems (CDSSs) leads to greater patient dissatisfaction and could increase noncompliance with preventative care and treatment recommendations.</description>
     <link>http://medicalxpress.com/news/2013-01-digital-diagnostic-tools-patient-dissatisfaction.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 24 Jan 2013 15:43:36 EST</pubDate>
	 <guid isPermaLink="false">news278264602</guid>
	 
</item>
<item>
     <title>Benefit of PET or PET/CT in recurrent bowel cancer is not proven</title>
   	 <description>For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in combination with computed tomography (CT). This is because no studies have directly compared the benefits of these imaging techniques in recurrent colorectal carcinoma (bowel cancer) with conventional diagnostic techniques. Although PET or PET/CT show a higher diagnostic accuracy, i.e. in certain cases recurrences can be detected more reliably, it is still unclear how this actually affects patient-relevant outcomes such as quality of life. This is the conclusion of the final report of the German Institute for Quality and Efficiency in Health Care (IQWiG) published on 24th October 2012.</description>
     <link>http://medicalxpress.com/news/2012-12-benefit-pet-petct-recurrent-bowel.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 10 Dec 2012 11:49:28 EST</pubDate>
	 <guid isPermaLink="false">news274362561</guid>
	 
</item>
<item>
     <title>Mitral valve repair safe and effective for elderly patients once considered too high risk based on age alone</title>
   	 <description>(Medical Xpress)—Heart surgery to repair the mitral valve is safe and leads to a better quality of life for older patients long-suspected to be too high risk for the operation, according to new research from the University of Pittsburgh School of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-12-mitral-valve-safe-effective-elderly.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 04 Dec 2012 07:52:43 EST</pubDate>
	 <guid isPermaLink="false">news273829950</guid>
	 
</item>
<item>
     <title>Benefit of PET and PET/CT in ovarian cancer is not proven</title>
   	 <description>Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, in certain cases, recurrences can be detected earlier and more accurately with PET or PET/CT than with conventional imaging techniques. This is the conclusion of the final report by the German Institute for Quality and Efficiency in Health Care (IQWiG) in Cologne that was published on 23 May 2012.</description>
     <link>http://medicalxpress.com/news/2012-08-benefit-pet-petct-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 08 Aug 2012 10:26:36 EST</pubDate>
	 <guid isPermaLink="false">news263640390</guid>
	 
</item>
<item>
     <title>Study examines drug regimen for the treatment of non-small cell lung cancer among older patients</title>
   	 <description>Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-drug-regimen-treatment-non-small-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 17 Apr 2012 10:51:03 EST</pubDate>
	 <guid isPermaLink="false">news253878657</guid>
	 
</item>
<item>
     <title>IDSA/PIDS announce guidelines for treating pneumonia in children</title>
   	 <description>Immunizations, including a yearly flu vaccine, are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA).</description>
     <link>http://medicalxpress.com/news/2011-08-idsapids-guidelines-pneumonia-children.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 31 Aug 2011 06:07:09 EST</pubDate>
	 <guid isPermaLink="false">news233989616</guid>
	 
</item>


</channel>
</rss>
